Marsh & McLennan CEO Doyle John Q sells 21,079 shares, buys same amount at lower price.

miércoles, 3 de septiembre de 2025, 4:11 pm ET1 min de lectura
MMC--

Marsh & McLennan Companies, Inc. [MMC] recently disclosed that President and CEO Doyle John Q executed a transaction involving the sale of 21,079 shares at a price of $205.65 per share on September 2, 2025. Concurrently, Doyle John Q also acquired 21,079 shares at a price of $63.09 per share on the same date.

Marsh & McLennan Companies, Inc. [MMC] recently disclosed that President and CEO John Q. Doyle executed a significant transaction involving the exercise and sale of stock options. On September 2, 2025, Doyle exercised 21,079 stock options at an exercise price of $63.09 per share and immediately sold 21,079 shares at $205.65 per share [1].

The transactions were executed pursuant to a previously adopted Rule 10b5-1 trading plan, indicating a routine liquidity event rather than a special issuance or amendment. After these transactions, Doyle beneficially owned 87,681.0205 shares of MMC directly.

The options exercised were originally granted on May 1, 2016, and vested in four equal annual installments beginning May 1, 2017, with full vesting by 2020. This structured vesting schedule aligns with best practices in corporate governance, ensuring that executives have a long-term interest in the company's success.

From a disclosure and compliance viewpoint, the reliance on a 10b5-1 plan and the fact that the options were long-vested (granted in 2016 and fully vested by 2020) indicate a routine liquidity event rather than a special issuance or amendment. The Form 4 filing includes an attorney-in-fact signature confirming the timely filing, ensuring transparency and compliance with regulatory requirements.

The transaction follows governance best practices by using a documented 10b5-1 plan, and no new benefit plan grants were disclosed. The Form 4 shows the CEO transacted under a declared trading plan, which provides an affirmative defense under Rule 10b5-1. The filing discloses the original grant date and vesting schedule for the options (May 1, 2016, vested in four installments through 2020), supporting clarity on option maturity.

References:
[1] https://www.stocktitan.net/sec-filings/MMC/form-4-marsh-mc-lennan-companies-inc-insider-trading-activity-c85bd1fc9eb2.html

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios